These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2173509)
21. Studies on the mechanism of action of the gastric microsomal (H+ + K+)-ATPase inhibitors SCH 32651 and SCH 28080. Scott CK; Sundell E; Castrovilly L Biochem Pharmacol; 1987 Jan; 36(1):97-104. PubMed ID: 3026407 [TBL] [Abstract][Full Text] [Related]
24. Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa. Elander B; Fellenius E; Leth R; Olbe L; Wallmark B Scand J Gastroenterol; 1986 Apr; 21(3):268-72. PubMed ID: 3012768 [TBL] [Abstract][Full Text] [Related]
25. Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion. Wallmark B; Jaresten BM; Larsson H; Ryberg B; Brändström A; Fellenius E Am J Physiol; 1983 Jul; 245(1):G64-71. PubMed ID: 6307064 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of gastric H,K-ATPase activity and gastric epithelial cell IL-8 secretion by the pyrrolizine derivative ML 3000. Smolka AJ; Goldenring JR; Gupta S; Hammond CE BMC Gastroenterol; 2004 Feb; 4():4. PubMed ID: 15028114 [TBL] [Abstract][Full Text] [Related]
27. Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups. Im WB; Sih JC; Blakeman DP; McGrath JP J Biol Chem; 1985 Apr; 260(8):4591-7. PubMed ID: 2985559 [TBL] [Abstract][Full Text] [Related]
28. Coupling of H(+)-K(+)-ATPase activity and glucose oxidation in gastric glands. Fryklund J; Gedda K; Scott D; Sachs G; Wallmark B Am J Physiol; 1990 May; 258(5 Pt 1):G719-27. PubMed ID: 2159239 [TBL] [Abstract][Full Text] [Related]
29. Antisecretory actions of Baccharis trimera (Less.) DC aqueous extract and isolated compounds: analysis of underlying mechanisms. Biondo TM; Tanae MM; Coletta ED; Lima-Landman MT; Lapa AJ; Souccar C J Ethnopharmacol; 2011 Jun; 136(2):368-73. PubMed ID: 21575703 [TBL] [Abstract][Full Text] [Related]
30. Reversible inhibition of sodium and potassium-dependent adenosine triphosphatase by the pyridine derivative, AU-1421 during turnover cycle. Takada J Biochem Pharmacol; 1990 Oct; 40(7):1527-31. PubMed ID: 2171532 [TBL] [Abstract][Full Text] [Related]
31. Gastric H+-K+-ATPase in situ: evidence for compartmentalization. Hersey SJ; Perez A; Matheravidathu S; Sachs G Am J Physiol; 1989 Oct; 257(4 Pt 1):G539-47. PubMed ID: 2552824 [TBL] [Abstract][Full Text] [Related]
32. Effects of verapamil on gastric acid secretion in vitro and in vivo. Herling AW; Ljungström M Eur J Pharmacol; 1988 Nov; 156(3):341-50. PubMed ID: 2850932 [TBL] [Abstract][Full Text] [Related]
33. Rapid inhibition of the K(+)-sensitive phosphoenzyme of Na+/K(+)-ATPase by (Z)-5-methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine. Takada J; Fukushima Y Biochim Biophys Acta; 1991 Jun; 1065(2):153-9. PubMed ID: 1647819 [TBL] [Abstract][Full Text] [Related]
34. Syntaxin 3 is required for cAMP-induced acid secretion: streptolysin O-permeabilized gastric gland model. Ammar DA; Zhou R; Forte JG; Yao X Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G23-33. PubMed ID: 11751154 [TBL] [Abstract][Full Text] [Related]
35. Nicotinamide derivatives as a new class of gastric H+/K(+)-ATPase inhibitors. 1. Synthesis and structure-activity relationships of N-substituted 2-(benzhydryl- and benzylsulfinyl)nicotinamides. Terauchi H; Tanitame A; Tada K; Nakamura K; Seto Y; Nishikawa Y J Med Chem; 1997 Jan; 40(3):313-21. PubMed ID: 9022797 [TBL] [Abstract][Full Text] [Related]
36. Cibenzoline, an ATP-sensitive K(+) channel blocker, binds to the K(+)-binding site from the cytoplasmic side of gastric H(+),K(+)-ATPase. Tabuchi Y; Yashiro H; Hoshina S; Asano S; Takeguchi N Br J Pharmacol; 2001 Dec; 134(8):1655-62. PubMed ID: 11739241 [TBL] [Abstract][Full Text] [Related]
37. E3710, a new proton pump inhibitor, with a long-lasting inhibitory effect on gastric acid secretion. Kodama K; Fujisaki H; Kubota A; Kato H; Hirota K; Kuramochi H; Murota M; Tabata Y; Ueda M; Harada H; Kawahara T; Shinoda M; Watanabe N; Iida D; Terauchi H; Yasui S; Miyazawa S; Nagakawa J J Pharmacol Exp Ther; 2010 Aug; 334(2):395-401. PubMed ID: 20484556 [TBL] [Abstract][Full Text] [Related]
38. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione. Fujisaki H; Shibata H; Oketani K; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Yamaguchi M; Sakai H; Takeguchi N Biochem Pharmacol; 1991 Jul; 42(2):321-8. PubMed ID: 1650210 [TBL] [Abstract][Full Text] [Related]
39. Effects of NC-1300-B, a new benzimidazole derivative, on hog gastric H+, K+-ATPase, gastric acid secretion and HCl.ethanol-induced gastric lesions in rats. Okabe S; Akimoto Y; Yamasaki S; Nagai H Dig Dis Sci; 1988 Nov; 33(11):1425-34. PubMed ID: 2846250 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole. Wallmark B; Briving C; Fryklund J; Munson K; Jackson R; Mendlein J; Rabon E; Sachs G J Biol Chem; 1987 Feb; 262(5):2077-84. PubMed ID: 3029064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]